What do you monitor?
Curated feeds for your role. Pick your area and get exactly the sources you need.
Compliance & Legal
Legal Research
Court opinions, regulatory guidance, and enforcement actions. AI-summarized.
Financial Compliance
SEC, OCC, FDIC, Fed, FINRA, CFPB, FASB, and state banking regulators. One feed.
Insurance Compliance
State commissioner bulletins, NAIC model laws, and DOI enforcement actions.
Environmental Compliance
EPA enforcement, state environmental agencies, PFAS regulatory updates.
Data Privacy
State AG privacy enforcement, FTC actions, CPPA rulemaking, and HIPAA enforcement.
Tax Compliance
IRS guidance changes and state tax department bulletins.
AML Compliance
FinCEN, OCC, FDIC, Fed, FATF, and banking regulator enforcement.
Labor & Employment
NLRB decisions, EEOC guidance, DOL wage updates, and 50-state labor law changes.
Immigration Law
USCIS policy changes, visa bulletin updates, CBP processing changes.
Industry
Pharma & Life Sciences
FDA warning letters, drug approvals, ICH guidelines, EMA updates, and DEA scheduling.
Energy & Utilities
FERC orders, state PUC decisions, and energy regulatory changes.
Cybersecurity
CISA KEV catalog, ICS-CERT, NSA advisories, NIST CSF, and FedRAMP updates.
Healthcare Compliance
CMS transmittals, OIG work plan, HIPAA enforcement, and Medicaid updates.
Trade & Procurement
Recent changes
ACME UNITED CORPORATION Class II Drug Recall
The FDA has initiated a Class II drug recall for ACME UNITED CORPORATION's Max Packaging Antibacterial Towelette due to CGMP deviations. The recall affects product distributed nationwide within the United States and is ongoing.
ACME UNITED CORPORATION Class II Recall of Antiseptic Wipes
The FDA has announced a Class II recall for ACME UNITED CORPORATION's Medi-First Antiseptic Wipes due to CGMP deviations. The recall affects product distributed nationwide in the United States.
ACME UNITED CORPORATION Class II Drug Recall
The FDA has initiated a Class II drug recall for Dukal BZK Antiseptic Towelettes manufactured by ACME UNITED CORPORATION due to CGMP deviations. The recall affects product distributed nationwide in the United States.
FDA Class II Drug Recall: Harbin Jixianglong Semaglutide
The FDA has initiated a Class II recall for Semaglutide distributed by Harbin Jixianglong Biotech Co., Ltd. nationwide due to CGMP deviations, specifically failing to complete process validation and bacterial endotoxin method validation before distribution. The recall is ongoing.
Mylan Pharmaceuticals Class II Drug Recall: Isotretinoin Capsules
The FDA has announced a Class II drug recall for Mylan Pharmaceuticals' Isotretinoin Capsules, USP 40 mg, due to failed dissolution specifications. The recall affects product distributed nationwide within the United States.
Radnostix Class II Drug Recall for Sodium Iodide
The FDA has initiated a Class II drug recall for Radnostix's Sodium Iodide (I-131) Solution, identified as D-0389-2026. The recall is due to the presence of particulate matter resulting from production issues and affects distribution nationwide in the USA and Puerto Rico.
Teva Pharmaceuticals Class II Recall of Metoprolol Succinate Tablets
The FDA has issued a Class II recall for Teva Pharmaceuticals' Metoprolol Succinate Extended-Release Tablets due to failed dissolution specifications. The recall affects nationwide distribution and is currently ongoing.
FDA Class II Recall of Antiseptic Wipes
The FDA has initiated a Class II recall for Green Guard Antiseptic Wipes due to CGMP deviations. The product was distributed nationwide in the United States. This recall is ongoing.
Teva Pharmaceuticals USA, Inc. - Metoprolol Succinate Recall
The FDA has initiated a Class II recall for Teva Pharmaceuticals USA, Inc.'s Metoprolol Succinate Extended-Release Tablets (200 mg) due to failed dissolution specifications. The recall is nationwide and affects approximately 100-count bottles.
ACME UNITED CORPORATION Class II Recall D-0370-2026 for Towelettes
The FDA has issued a Class II recall (D-0370-2026) for ACME UNITED CORPORATION's Cleansing Towelettes due to CGMP deviations. The recall is ongoing and affects nationwide distribution within the United States.
Browse by country
United States
1830 sources
United Kingdom
88 sources
European Union
78 sources
Canada
36 sources
International
33 sources
Australia
22 sources
Singapore
21 sources
India
13 sources
France
11 sources
Italy
8 sources
Hong Kong
7 sources
Japan
7 sources
Ireland
6 sources
Switzerland
6 sources
MT
5 sources
Germany
5 sources
Poland
5 sources
Luxembourg
4 sources
New Zealand
4 sources
GH
3 sources
NG
3 sources
South Korea
2 sources
KE
2 sources
KY
2 sources
Netherlands
2 sources
South Africa
2 sources
UAE
2 sources
Austria
2 sources
CL
2 sources
CY
2 sources
GG
2 sources
GI
2 sources
IL
1 sources
Hungary
1 sources
Uganda
1 sources
BM
1 sources
SE
1 sources
SA
1 sources
Romania
1 sources
Croatia
1 sources
CO
1 sources
Norway
1 sources
Greece
1 sources
DK
1 sources
MU
1 sources
Spain
1 sources
Finland
1 sources
LK
1 sources
Browse by category
Courts & Legal
360 sources
Government & Legislation
326 sources
Banking & Finance
266 sources
Healthcare
136 sources
Trade & Sanctions
124 sources
Labor & Employment
113 sources
Energy
107 sources
Securities & Markets
104 sources
Pharma & Drug Safety
103 sources
Environment
85 sources
Data Privacy & Cybersecurity
74 sources
Tax
65 sources
Agriculture & Food Safety
63 sources
Insurance
58 sources
Transportation
57 sources
Defense & National Security
52 sources
Telecom & Technology
47 sources
Consumer Protection
44 sources
Education
20 sources
Housing
16 sources
Immigration
9 sources
AI Regulation
3 sources
Legal & Courts
1 sources
Consumer & Competition
1 sources
Tax & Revenue
1 sources
Browse by agency
BIS
12 sources
CFPB
11 sources
USTR
11 sources
DOL
11 sources
JD Supra
11 sources
CBP
10 sources
Federal Reserve
9 sources
OCC
8 sources
USCIS
8 sources
NIST
8 sources
FTC
8 sources
FDIC
7 sources
CPSC
7 sources
Congress
7 sources
CMS
7 sources
ICO
7 sources
OSHA
7 sources
Courts
7 sources
DOE
6 sources
State Medical Board
6 sources
Get alerts when regulations change
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.